While admissions to AIM in Q2 were down year on year, continuing the trend from Q1, secondary issues have forged ahead and are at levels not seen since 1999.
A medical device company focussing on the development and commercialisation of innovative orthopaedic medical devices for the spine and trauma markets has joined AIM.
A Kazakhstan-based company that was formed last year to develop oil and gas assets in Central Asia has joined AIM. Roxi Petroleum raised £38.9 million from the admission after its shares were priced at 38p each.
Pharmaceutical group China Medical System Holdings (CMSH) commenced trading on AIM this week. Its placing price was 138p and it is now trading around 146p.
Water technology developer Modern Water has announced its intention to float on AIM. The company is one of three subsidiaries of IP Group, which seeks to commercialise intellectual property (IP), and is the first of these to enter the public market.
